Literature DB >> 17360246

NHEJ protects mycobacteria in stationary phase against the harmful effects of desiccation.

Robert S Pitcher1, Andrew J Green, Anna Brzostek, Malgorzata Korycka-Machala, Jaroslaw Dziadek, Aidan J Doherty.   

Abstract

The physiological role of the non-homologous end-joining (NHEJ) pathway in the repair of DNA double-strand breaks (DSBs) was examined in Mycobacterium smegmatis using DNA repair mutants (DeltarecA, Deltaku, DeltaligD, Deltaku/ligD, DeltarecA/ku/ligD). Wild-type and mutant strains were exposed to a range of doses of ionizing radiation at specific points in their life-cycle. NHEJ-mutant strains (Deltaku, DeltaligD, Deltaku/ligD) were significantly more sensitive to ionizing radiation (IR) during stationary phase than wild-type M. smegmatis. However, there was little difference in IR sensitivity between NHEJ-mutant and wild-type strains in logarithmic phase. Similarly, NHEJ-mutant strains were more sensitive to prolonged desiccation than wild-type M. smegmatis. A DeltarecA mutant strain was more sensitive to desiccation and IR during both stationary and especially in logarithmic phase, compared to wild-type strain, but it was significantly less sensitive to IR than the DeltarecA/ku/ligD triple mutant during stationary phase. These data suggest that NHEJ and homologous recombination are the preferred DSB repair pathways employed by M. smegmatis during stationary and logarithmic phases, respectively.

Entities:  

Mesh:

Year:  2007        PMID: 17360246     DOI: 10.1016/j.dnarep.2007.02.009

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  41 in total

1.  Characterization of the roles of the catalytic domains of Mycobacterium tuberculosis ligase D in Ku-dependent error-prone DNA end joining.

Authors:  Douglas Wright; Austin DeBeaux; Runhua Shi; Aidan J Doherty; Lynn Harrison
Journal:  Mutagenesis       Date:  2010-06-07       Impact factor: 3.000

2.  Multiple Ku orthologues mediate DNA non-homologous end-joining in the free-living form and during chronic infection of Sinorhizobium meliloti.

Authors:  Hajime Kobayashi; Lyle A Simmons; Daniel S Yuan; William J Broughton; Graham C Walker
Journal:  Mol Microbiol       Date:  2007-12-07       Impact factor: 3.501

3.  The pathways and outcomes of mycobacterial NHEJ depend on the structure of the broken DNA ends.

Authors:  Jideofor Aniukwu; Michael S Glickman; Stewart Shuman
Journal:  Genes Dev       Date:  2008-02-15       Impact factor: 11.361

4.  AdnAB: a new DSB-resecting motor-nuclease from mycobacteria.

Authors:  Krishna Murari Sinha; Mihaela-Carmen Unciuleac; Michael S Glickman; Stewart Shuman
Journal:  Genes Dev       Date:  2009-05-26       Impact factor: 11.361

Review 5.  Recombinational DNA repair in a cellular context: a search for the homology search.

Authors:  Allon Weiner; Nathan Zauberman; Abraham Minsky
Journal:  Nat Rev Microbiol       Date:  2009-10       Impact factor: 60.633

6.  Characterization of the mycobacterial AdnAB DNA motor provides insights into the evolution of bacterial motor-nuclease machines.

Authors:  Mihaela-Carmen Unciuleac; Stewart Shuman
Journal:  J Biol Chem       Date:  2009-11-17       Impact factor: 5.157

Review 7.  CarD: a new RNA polymerase modulator in mycobacteria.

Authors:  Christina L Stallings; Michael S Glickman
Journal:  Transcription       Date:  2011 Jan-Feb

8.  Deficiency of double-strand DNA break repair does not impair Mycobacterium tuberculosis virulence in multiple animal models of infection.

Authors:  Brook E Heaton; Daniel Barkan; Paola Bongiorno; Petros C Karakousis; Michael S Glickman
Journal:  Infect Immun       Date:  2014-05-19       Impact factor: 3.441

9.  Bacterial nonhomologous end joining requires teamwork.

Authors:  Lindsay A Matthews; Lyle A Simmons
Journal:  J Bacteriol       Date:  2014-07-21       Impact factor: 3.490

10.  Bacterial nonhomologous end joining ligases preferentially seal breaks with a 3'-OH monoribonucleotide.

Authors:  Hui Zhu; Stewart Shuman
Journal:  J Biol Chem       Date:  2008-01-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.